Martina Schafer-Benesova
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer.
Journal: Molecular pharmaceutics
Published: March 03, 2026
Differential Radiobiological Effects of Αlpha- and Beta-Minus-Emitter Targeted Radionuclide Therapy: DNA Damage and Survival.
Journal: International journal of radiation oncology, biology, physics
Published: January 15, 2026
EpCAM-PSMA: Potential predictors of treatment outcomes for PSMA-targeted alpha therapies in metastatic castration-resistant prostate cancer.
Journal: Molecular therapy. Oncology
Published: November 18, 2025
The Discovery of Prostate-specific Membrane Antigen Ligands: The Long Road to Changes in Clinical Practice for Prostate Cancer.
Journal: European urology
Published: November 07, 2025
Genomic analysis in chemotherapy-naïve prostate cancer prior to PSMA-targeted treatment.
Journal: Frontiers in oncology
Published: November 06, 2025
Exploratory case series of circulating tumor DNA dynamics during tandem therapy in metastatic castration-resistant prostate cancer.
Journal: EJNMMI research
Published: October 02, 2025
High-energy resolution X-ray spectroscopy reveals bonding characteristics of La3+ homologues of actinium radiopharmaceuticals.
Journal: Communications chemistry
Published: September 10, 2025
Advancing towards cancer theragnostic by probing the 225Ac decay chain with ultra-high-resolution metallic magnetic calorimeter based detectors.
Journal: Communications medicine
Published: July 12, 2025
Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modifications.
Journal: EJNMMI radiopharmacy and chemistry
Published: July 10, 2025
Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 19, 2025
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 03, 2025
Last Updated: 09/26/2026